Zubeen Shroff

Zubeen Shroff is the Managing Partner at Galen Partners, a healthcare growth equity firm based in Stamford, Connecticut. Before joining Galen in 1997, he served as a Principal at The Wilkerson Group, which was later acquired by IBM, and began his career launching alpha-Interferon at Schering-Plough Pharmaceuticals. Over his 30-year investment career, Shroff has directed capital across specialty pharmaceuticals, medical devices, and technology-enabled services, holding board seats at companies including MiniMed, Acura Pharmaceuticals, and Encore Medical. He currently serves as the Chair of the Boston University School of Public Health Dean’s Advisory Board and Chair of the Westchester County Health Care Corporation Board of Directors. Holding an MBA from the Wharton School and a BA in Biological Sciences from Boston University, Shroff maintains a primary focus on partnering with healthcare entrepreneurs to scale growth-stage medical enterprises.